NFKB1 and steatosis: These findings suggest that HAS exerts a preventive effect against hepatic vacuolating steatosis in IR model mice and that the underlying mechanism may be associated with the activation of the PI3K/Akt/INS signaling pathway and the NF-kB signaling pathway.